Supercharge Your Go-to-Market Strategy
Life Science & Biopharma

Supercharge Your Go-to-Market Strategy

Eko transforms the point of care critical interaction to help you identify the right patients who can benefit from your therapy.

Book Demo

Get more patients into your pipeline. Whether in-clinic disease detection or at-home remote monitoring, Eko's digital stethoscopes and AI generate clinical insight that can support your market development activities.

How Eko Enables Commercial Development

How Eko Enables Commercial Development
Support Point-of-Care Disease Detection

Hundreds of thousands of clinicians use Eko’s digital stethoscope technology at the point of care to screen patients for cardiopulmonary symptoms:

  • Shortness of breath
  • Structural heart disease
  • Heart failure (pending FDA approval)
  • Pulmonary hypertension (algorithm in development)
  • Respiratory disease (on roadmap)
Accelerate Diagnosis & Shorten Time to Treatment

Many high-burden diseases like heart failure, COPD, and pulmonary hypertension are under-diagnosed and undertreated.

Eko’s SENSORA™ platform and Care Pathway Analytics help with earlier detection and visibility into downstream diagnostics and treatment.

Support Remote Patient Monitoring

Eko Teleheath remotely collects physiological data that offer key insight into cardiac and respiratory function, reducing the amount of in-person visits  without reducing quality of care. 

Eko enables clinicians to monitor:

  • Structural heart function 
  • Respiratory function via lung sounds
  • Electro-mechanical activation time (with applications in heart failure)
  • Atrial fibrillation
  • Reduced ejection fraction (pending FDA approval)

Schedule a Demo

CORE for Form

SENSORA Murmur Detection is available only in the US.